Literature DB >> 11865279

Hearing loss is a common feature of symptomatic children with profound biotinidase deficiency.

Barry Wolf1, Robert Spencer, Tucker Gleason.   

Abstract

Sensorineural hearing loss occurs in approximately 75% of symptomatic children with profound biotinidase deficiency, which is more common than originally thought. The hearing loss varies in severity and is usually irreversible. The biochemical, genotype, and clinical variations do not correlate with the development of hearing loss. Thus, it is very important to diagnose the disorder early, especially by newborn screening, to prevent the hearing loss.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11865279     DOI: 10.1067/mpd.2002.121938

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

1.  Rare Treatable Cause of Demyelinating Leukoencephalopathy That One Cannot Afford to Miss.

Authors:  Vykuntaraju K Gowda; Sukanya Vignesh; Balamurugan Nagarajan; Varunvenkat M Srinivasan; Manojna Battina; Maya Bhat; Rita Christopher
Journal:  J Pediatr Genet       Date:  2020-12-18

2.  Cochlear Implantation in Biotinidase Enzyme Deficiency.

Authors:  Ashish Castellino; Rahul Kurkure; Pabina Rayamajhi; Mohan Kameswaran
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-08-31

3.  Developmental window of sensorineural deafness in biotinidase-deficient mice.

Authors:  Kathleen June Maheras; Kirit Pindolia; Barry Wolf; Alexander Gow
Journal:  J Inherit Metab Dis       Date:  2017-05-17       Impact factor: 4.982

4.  High incidence of profound biotinidase deficiency detected in newborn screening blood spots in the Somalian population in Minnesota.

Authors:  K Sarafoglou; K Bentler; A Gaviglio; K Redlinger-Grosse; C Anderson; M McCann; B Bloom; D Babovic-Vuksanovic; D Gavrilov; S A Berry
Journal:  J Inherit Metab Dis       Date:  2009-09-07       Impact factor: 4.982

5.  Biotinidase deficiency: a reversible metabolic encephalopathy. Neuroimaging and MR spectroscopic findings in a series of four patients.

Authors:  Shrinivas Desai; Karthik Ganesan; Anaita Hegde
Journal:  Pediatr Radiol       Date:  2008-06-11

6.  Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics.

Authors:  Erin T Strovel; Tina M Cowan; Anna I Scott; Barry Wolf
Journal:  Genet Med       Date:  2017-07-05       Impact factor: 8.822

7.  Audit of Organic Acidurias from a Single Centre: Clinical and Metabolic Profile at Presentation with Long Term Outcome.

Authors:  Seema Pavaman Sindgikar; Krithika Damodar Shenoy; Nutan Kamath; Rathika Shenoy
Journal:  J Clin Diagn Res       Date:  2017-09-01

8.  Biotinidase Deficiency: New Directions and Practical Concerns.

Authors:  Barry Wolf
Journal:  Curr Treat Options Neurol       Date:  2003-07       Impact factor: 3.972

9.  Vitamin-responsive epileptic encephalopathies in children.

Authors:  Satish Agadi; Michael M Quach; Zulfi Haneef
Journal:  Epilepsy Res Treat       Date:  2013-07-25

10.  Biotinidase deficiency: a reversible neurometabolic disorder (an Iranian pediatric case series).

Authors:  Parvaneh Karimzadeh; Farzad Ahmadabadi; Narjes Jafari; Sayena Jabbehdari; Mohammad Reza Alaee; Mohammad Ghofrani; Mohammad Mahdi Taghdiri; Seyed Hassan Tonekaboni
Journal:  Iran J Child Neurol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.